Terry Cheung
Family · Lakewood, CONPI 1457731937
Payments from drug & device makers
Across 479 payments — averaging $23.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Electromed, Inc.$1K
- Medtronic$741
- AstraZeneca$672
- Amgen$591
- Johnson & Johnson$589
- plus $5K from 48 others
What the payments were for
- Consulting fees$1,09010%
- Speaking & faculty fees$340%
- Travel & lodging$2152%
- Food & beverage$9,94988%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$11,299 in reported general payments places this provider in the 95th percentile of 2,182 family providers in Colorado.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| StrensiqAsfotase Alfa | 21 | $2,303,624 |
| OzempicSemaglutide | 21 | $33,757 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 35 | $30,557 |
| MounjaroTirzepatide | 24 | $26,539 |
| EliquisApixaban | 19 | $18,433 |
| Tresiba Flextouch U-200Insulin Degludec | 20 | $15,476 |
| BelsomraSuvorexant | 13 | $5,506 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 17 | $2,884 |
| Lidocaine | 14 | $2,274 |
| Mometasone Furoate | 14 | $1,640 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 15 | $1,528 |
| Gabapentin | 21 | $1,191 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 24 | $1,028 |
| Diphenhydramine Hcl | 16 | $991 |
| Trazodone Hcl | 17 | $725 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaStrensiq | $672 | $2,303,62421 claims |
| Novo NordiskOzempic | $161 | $33,75721 claims |
| GSKTrelegy Ellipta | $241 | $30,55735 claims |
| Lilly USA, LLCMounjaro | $542 | $26,53924 claims |
| PfizerEliquis | $288 | $18,43319 claims |
| MerckBelsomra | $32 | $5,50613 claims |
| Sanofi-aventis U.S. LLCLantus | $14 | $60612 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $13 | $44155 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,182 family providers in Colorado.
Other family in Lakewood
- Laura GrahamLakewood$1.6M
- Brenda SassenLakewood$15K
- Ashley McKillopLakewood$14K
- Danielle MarstonLakewood$10K
- Elizabeth HammondLakewood$9K
- Maryann StraleyLakewood$8K
- Megan EdwardsLakewood$7K
- Lee MorseLakewood$7K
- Corinne YoungColorado Springs$272K
- Margaret MachaffieColorado Springs$97K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.